Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Boehme

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Deutsche Medizinische Wochenschrift (1946)|June 5, 2019
[The Polypill - A Practicable Approach?]Petra A Thürmann, Adina G Kleinerüschkamp, Philip Boehme
Der Urologe. Ausg. A|October 13, 2021
[New German laws on organ donation-clinicians' perspectives on effects, potential and limitations]Zoë Fehring, Philip Boehme, Stefan Wirth, et al.
Drug Discovery Today|October 29, 2022
The clinical supply of cell and gene therapy drugs: Challenges aheadThomas Fehm, Philip Boehme, Nehal Modak, et al.
Medical Hypotheses|October 23, 2017
New digital adherence devices could prevent millions of strokes from atrial fibrillation by the end of the next centuryPhilip Boehme, Peter Wienand, Maximilian Herrmann, et al.
MMW Fortschritte Der Medizin|April 22, 2022
[GPs education about organ donation: what factors influence the success?]Zoë Fehring, Philip Boehme, Stefan Wirth, et al.
Research in Social & Administrative Pharmacy : RSAP|May 24, 2023
Reasons for supply side driven drug shortages - A mixed-methods study on first-level, higher-level, and root causes from the perspective of marketing authorization holdersCelina Bade, Alexandra Olsacher, Philip Boehme, et al.
Molecular Therapy. Nucleic Acids|July 20, 2016
A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced IntegrationPhilip Boehme, Wenli Zhang, Manish Solanki, et al.
BJU International|February 17, 2018
Shortcomings in the management of undescended testis: guideline intention vs reality and the underlying causes - insights from the biggest German cohortPhilip Boehme, Berit Geis, Johannes Doerner, et al.
Current Gene Therapy|January 27, 2015
The sleeping beauty transposon vector system for treatment of rare genetic diseases: an unrealized hope?Philip Boehme, Johannes Doerner, Manish Solanki, et al.
Drug Discovery Today|October 24, 2021
Toward the institutionalization of quantum computing in pharmaceutical researchMaximillian Zinner, Florian Dahlhausen, Philip Boehme, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Deutsche Medizinische Wochenschrift (1946)|June 5, 2019
[The Polypill - A Practicable Approach?]Petra A Thürmann, Adina G Kleinerüschkamp, Philip Boehme
Der Urologe. Ausg. A|October 13, 2021
[New German laws on organ donation-clinicians' perspectives on effects, potential and limitations]Zoë Fehring, Philip Boehme, Stefan Wirth, et al.
Drug Discovery Today|October 29, 2022
The clinical supply of cell and gene therapy drugs: Challenges aheadThomas Fehm, Philip Boehme, Nehal Modak, et al.
Medical Hypotheses|October 23, 2017
New digital adherence devices could prevent millions of strokes from atrial fibrillation by the end of the next centuryPhilip Boehme, Peter Wienand, Maximilian Herrmann, et al.
MMW Fortschritte Der Medizin|April 22, 2022
[GPs education about organ donation: what factors influence the success?]Zoë Fehring, Philip Boehme, Stefan Wirth, et al.
Research in Social & Administrative Pharmacy : RSAP|May 24, 2023
Reasons for supply side driven drug shortages - A mixed-methods study on first-level, higher-level, and root causes from the perspective of marketing authorization holdersCelina Bade, Alexandra Olsacher, Philip Boehme, et al.
Molecular Therapy. Nucleic Acids|July 20, 2016
A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced IntegrationPhilip Boehme, Wenli Zhang, Manish Solanki, et al.
BJU International|February 17, 2018
Shortcomings in the management of undescended testis: guideline intention vs reality and the underlying causes - insights from the biggest German cohortPhilip Boehme, Berit Geis, Johannes Doerner, et al.
Current Gene Therapy|January 27, 2015
The sleeping beauty transposon vector system for treatment of rare genetic diseases: an unrealized hope?Philip Boehme, Johannes Doerner, Manish Solanki, et al.
Drug Discovery Today|October 24, 2021
Toward the institutionalization of quantum computing in pharmaceutical researchMaximillian Zinner, Florian Dahlhausen, Philip Boehme, et al.
Pageof 4